Ultra-fast, sensitive and quantitative on-chip detection of group B streptococci in clinical samples.


Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
15 Jan 2019
Historique:
received: 08 05 2018
revised: 04 09 2018
accepted: 11 09 2018
entrez: 24 10 2018
pubmed: 24 10 2018
medline: 20 12 2018
Statut: ppublish

Résumé

PCR enables sensitive and specific detection of infectious disease agents, but application in point-of-care diagnostic testing remains scarce. A compact tool that runs PCR assays in less than a few minutes and that relies on mass-producible, disposable reactors could revolutionize while-you-wait molecular testing. We here exploit well-established semiconductor manufacturing processes to produce silicon ultra-fast quantitative PCR (UF-qPCR) chips that can run PCR protocols with limited assay optimization. A total of 110 clinical samples were analyzed for the detection of group B streptococci using both a validated benchtop and an on-chip qPCR assay. For the on-chip assay, the total reaction time was reduced after optimization to less than 5 min. The standard curve, spanning a concentration range of 5 log units, yielded a PCR efficiency of 94%. The sensitivity obtained was 96% (96/100; CI: 90-98%) and the specificity 70% (7/10; CI: 40-90%). We show that if melting analyses would be integrated, the obtained sensitivity would drop slightly to 93% (CI: 86-96%), while the specificity would increase to 100% (CI: 72% - 100%). In comparison to the benchtop reference qPCR assay performed on a LightCycler

Identifiants

pubmed: 30348381
pii: S0039-9140(18)30952-4
doi: 10.1016/j.talanta.2018.09.041
pii:
doi:

Substances chimiques

Antigens, Bacterial 0
SIP protein, Streptococcus group B 0
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-225

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Qing Cai (Q)

Imec, Kapeldreef 75, B-3001 Leuven, Belgium.

Maarten Fauvart (M)

Imec, Kapeldreef 75, B-3001 Leuven, Belgium.

Rodrigo Sergio Wiederkehr (RS)

Imec, Kapeldreef 75, B-3001 Leuven, Belgium.

Benjamin Jones (B)

Imec, Kapeldreef 75, B-3001 Leuven, Belgium.

Piet Cools (P)

Laboratory for Bacteriology Research, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Heymanslaan 10 185, Entrance 38 (MRB2), 9000 Gent, Belgium.

Peter Goos (P)

Division of Mechatronics, Biostatistics and Sensors (MeBioS), KU Leuven Kasteelpark Arenberg 30 - bus 2456, 3001 Leuven, Belgium; Department of Engineering Management, University of Antwerp, 2000 Antwerpen, Belgium.

Mario Vaneechoutte (M)

Laboratory for Bacteriology Research, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Heymanslaan 10 185, Entrance 38 (MRB2), 9000 Gent, Belgium.

Tim Stakenborg (T)

Imec, Kapeldreef 75, B-3001 Leuven, Belgium. Electronic address: tim.stakenborg@imec.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH